ARHGAP5 and cancer: miR-486 has been shown to participant in general tumorigenesis by targeting the anti-apoptotic OLFM4 [30], SIRT1 [31], PIM-1 [32] and protumorigenic ARHGAP5 [33] in various types of cancer.